Foot Ulcer clinical trials

Explore recruiting foot ulcer clinical trials.

Recruiting foot ulcer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Foot Ulcer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

NEurotrophins Mimetic compound for the treatment of diabetic foot UlcerS

Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A randomized double-blind clinical trial comparing Hypochlorous Acid and Polyhexamethylene biguanide in treating diabetic foot ulcers

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

(ESMERALD) A phase-2A, single-centre, prospective, uncontrolled, open label, single arm, exploratory clinical study to evaluate the safety and efficacy of cutaneous AUP1602-C with foam dressing as a treatment for non-healing neuroischemic diabetic foot ulcers

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase-2, multi-centre, prospective, randomized, standard-of-care plus placebo-controlled, patient and central evaluator blinded, parallel arm, clinical study to evaluate safety, tolerability and efficacy of the recommended phase-2 dose of AUP1602-C in two dosing frequencies as a topical treatment for non-healing neuro-ischemic diabetic foot ulcers

Poland, Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Healing Diabetic Foot Ulcers with Semaglutide

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Evaluation of the safety and efficacy of an advanced therapy medicinal product containing live ASCs in the treatment of diabetic foot syndrome – a double-blind, randomized study.

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Foot Ulcer trials by city

Foot Ulcer in Toronto Foot Ulcer in Vancouver Foot Ulcer in Montreal Foot Ulcer in Calgary Foot Ulcer in Edmonton Foot Ulcer in Ottawa Foot Ulcer in Winnipeg Foot Ulcer in Quebec City Foot Ulcer in Hamilton Foot Ulcer in Kitchener Foot Ulcer in London Foot Ulcer in Halifax Foot Ulcer in New York Foot Ulcer in Los Angeles Foot Ulcer in Chicago Foot Ulcer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease